| Weighted Average Stock Price to include additional shares in diluted share calculation [Table Text Block] |
The Company is required to include additional shares in its diluted shares outstanding calculation based on the treasury stock method when the average market price of a share of Omnicare stock on the New York Stock Exchange for the applicable period exceeds the following amounts:
| | | | | | Convertible Debt | | Price | 3.75% convertible senior subordinated notes, due 2025 | | $ | 26.84 |
| 4.00% junior subordinated convertible debentures, due 2033 | | $ | 40.82 |
| 3.25% convertible senior debentures, due 2035 | | $ | 77.88 |
| 3.75% convertible senior subordinated notes, due 2042 | | $ | 41.05 |
| 3.50% convertible senior subordinated notes, due 2044 | | $ | 70.00 |
|
|
| Schedule of Earnings Per Share, Basic and Diluted [Table Text Block] |
The following is a reconciliation of the basic and diluted earnings per share (“EPS”) computations for both the numerator and denominator (in thousands, except per share data): | | | | | | | | | | | | | | | | | | | | | | | | | | Three months ended September 30, | | Nine months ended September 30, | 2014: | | Income (Numerator) | | Common Shares(Denominator) | | Per Common
Share Amounts | | Income (Numerator) | | Common Shares(Denominator) | | Per Common
Share Amounts | Basic EPS | | | | | | | | | | | | | Income from continuing operations | | $ | 68,077 |
| | | | $ | 0.70 |
| | $ | 192,961 |
| | | | $ | 1.98 |
| Loss from discontinued operations | | (3,246 | ) | | | | (0.03 | ) | | (42,385 | ) | | | | (0.43 | ) | Net income | | $ | 64,831 |
| | 97,019 |
| | $ | 0.67 |
| | $ | 150,576 |
| | 97,521 |
| | $ | 1.54 |
| Effect of Dilutive Securities | | |
| | |
| | |
| | |
| | |
| | |
| Convertible securities | | 66 |
| | 7,945 |
| | |
| | 198 |
| | 8,283 |
| | |
| Stock options, units and awards | | — |
| | 584 |
| | |
| | — |
| | 646 |
| | |
| Diluted EPS | | |
| | |
| | |
| | |
| | |
| | |
| Income from continuing operations plus assumed conversions | | $ | 68,143 |
| | | | $ | 0.65 |
| | $ | 193,159 |
| | | | $ | 1.81 |
| Loss from discontinued operations | | (3,246 | ) | | | | (0.03 | ) | | (42,385 | ) | | | | (0.40 | ) | Net income plus assumed conversions | | $ | 64,897 |
| | 105,548 |
| | $ | 0.61 |
| | $ | 150,774 |
| | 106,450 |
| | $ | 1.42 |
|
| | | | | | | | | | | | | | | | | | | | | | | | | | Three months ended September 30, | | Nine months ended September 30, | 2013: | | Income (Numerator) | | Common Shares(Denominator) | | Per Common
Share Amounts | | Income (Numerator) | | Common Shares(Denominator) | | Per Common
Share Amounts | Basic EPS | | |
| | |
| | |
| | | | | | | Income (loss) from continuing operations | | $ | (69,351 | ) | | | | $ | (0.68 | ) | | $ | 26,265 |
| | | | $ | 0.26 |
| Income from discontinued operations | | 3,042 |
| | | | 0.03 |
| | 13,999 |
| | | | 0.14 |
| Net income (loss) | | $ | (66,309 | ) | | 101,811 |
| | $ | (0.65 | ) | | $ | 40,264 |
| | 102,624 |
| | $ | 0.39 |
| Effect of Dilutive Securities | | |
| | |
| | |
| | | | | | | Convertible securities | | — |
| | — |
| | |
| | 212 |
| | 6,360 |
| | | Stock options, warrants, units and awards | | — |
| | — |
| | |
| | — |
| | 628 |
| | | Diluted EPS | | |
| | |
| | |
| | | | | | | Income (loss) from continuing operations plus assumed conversions | | $ | (69,351 | ) | | | | $ | (0.68 | ) | | $ | 26,477 |
| | | | $ | 0.24 |
| Income from discontinued operations | | 3,042 |
| | | | 0.03 |
| | 13,999 |
| | | | 0.13 |
| Net income (loss) plus assumed conversions | | $ | (66,309 | ) | | 101,811 |
| | $ | (0.65 | ) | | $ | 40,476 |
| | 109,612 |
| | $ | 0.37 |
|
|